Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enamel hydroxyapatite is the primary inorganic constituent of human tooth enamel, comprising approximately 96% of its weight and providing the extreme hardness required for mastication (StatPearls, 2023). It consists of a crystalline lattice of calcium and phosphate ions, specifically Ca10(PO4)6(OH)2, which exists in a dynamic equilibrium of demineralization and remineralization within the oral environment (NIH, 2022). This mineral surface is a critical therapeutic target in preventive dentistry; for example, fluoride ions interact with the surface to replace hydroxyl groups, forming fluorapatite which is significantly more resistant to acid dissolution by cariogenic bacteria (Journal of Dentistry, 2019). Beyond caries prevention, the hydroxyapatite surface is targeted by remineralizing agents like nano-hydroxyapatite and CPP-ACP to repair early-stage 'white spot' lesions and restore mineral density (Nature, 2019). Additionally, therapeutic agents target this surface to treat dentin hypersensitivity by occluding exposed tubules and reducing fluid movement (Scientific Reports, 2020). Understanding the physicochemical properties of this surface is essential for developing treatments that combat dental erosion and maintain oral health.
Promotion of remineralization through ion deposition, substitution of hydroxyl groups with fluoride to form acid-resistant fluorapatite, and physical occlusion of dentinal tubules to block external stimuli.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enamel hydroxyapatite surface (HAP).